Cover: How to Integrate Pharmacotherapy for Substance Use Disorders at Your Mental Health Clinic

How to Integrate Pharmacotherapy for Substance Use Disorders at Your Mental Health Clinic

A Step-By-Step Guide for Screening and Treating Adults with Co-Occurring Mental Illness and Alcohol and/or Opioid Use Disorders with Pharmacotherapy in Mental Health Clinics

Published Jul 8, 2021

by Katherine E. Watkins, Allison J. Ober, Sarah B. Hunter, Brian Hurley, John Sheehe, Jeremy Martinez, Elizabeth Bromley, Derjung M. Tarn, Ivan Beas, Alanna Montero, et al.

View Online

Most people with co-occurring substance use and mental health disorders (COD) never get the high-quality care they need to recover. However, research shows that medications for COD can help clients achieve better outcomes. Delivering these medications in a setting where people with COD get most of their care can help increase uptake. To address this issue, RAND researchers created a toolkit to support the delivery of effective, evidence-based pharmacotherapy for clients with co-occurring alcohol use disorder (COD-alcohol) and co-occurring opioid use disorder (COD-opioid) within mental health clinics. The toolkit also guides supportive care, including screening and behavioral therapy, as well as program implementation and monitoring.

Users of the toolkit follow a four-step process to successfully integrate a COD-alcohol or COD-opioid care program in their mental health clinics. In Step 1, users identify key team members and learn how to engage them in implementing an integrated care program. In Step 2, users become familiar with the COD-alcohol or COD-opioid treatment workflow, decide which staff members will be responsible for each step of the process, and adapt the workflow to meet the specific needs of their clinics and care systems. In Step 3, users gather all of the resources needed to provide care in their clinics and assign and train staff on their roles. Finally, in Step 4, users begin treating clients with pharmacotherapy for their COD-alcohol or COD-opioid and monitoring their success.

Research conducted by

This research was prepared for the National Institute on Alcohol Abuse and Alcoholism and conducted by RAND Health Care.

This report is part of the RAND tool series. RAND tools may include models, databases, calculators, computer code, GIS mapping tools, practitioner guidelines, web applications, and various toolkits. All RAND tools undergo rigorous peer review to ensure both high data standards and appropriate methodology in keeping with RAND's commitment to quality and objectivity.

Our mission to help improve policy and decisionmaking through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behavior. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.